| |
Outcome
|
Measurement
|
Baseline screening
|
T0
|
T1
|
T2
|
T3
|
|---|
| | |
-interview (i)
| |
Pretreatment
|
Posttreatment
|
1 month FU
|
6 months FU
|
|---|
| | |
-self-report (s)
| | | | | |
|---|
| | |
-reaction time (r)
| | | | | |
|---|
| | |
-bloodsample (b)
| | | | | |
|---|
|
1
|
Recent and lifetime use, indications for psychiatric or medical evaluation, addiction treatment history and current abuse or dependence (DSM-IV)
|
MATE (part 1–4) (i)
|
X
| | | | |
|
2
|
Comorbid psychiatry (DSM-IV)
|
MINI-plus (i)
|
X
| | | | |
|
3
|
Motivation to change
|
RCQ-D (s)
| |
X
| | | |
|
4
|
Harmful alc. use
|
AUDIT (30 d) (s)
| |
X
|
X
|
X
|
X
|
|
5
|
Self-efficacy
|
SELD (s)
| |
X
|
X
|
X
|
X
|
|
6
|
Health outcome
|
EQ-5D (s)
| |
X
|
X
|
X
|
X
|
|
7
|
Quality of life
|
CRA-HS (s)
| |
X
|
X
|
X
|
X
|
|
8
|
Alcohol craving
|
PACS (s)
| |
X
|
X
|
X
|
X
|
|
9
|
Desire thinking
|
DTQ (s)
| |
X
|
X
|
X
|
X
|
|
10
|
Pos. and neg. affect
|
PANAS-SF (s)
| |
X
|
X
|
X
|
X
|
|
11
|
Rumination
|
PTQ (s)
| |
X
|
X
|
X
|
X
|
|
12
|
Drinking behavior
|
TLFB (30 d) (i)
| |
X
|
X
|
X
|
X
|
|
13
|
Alcohol attentional bias
|
Alcohol Stroop (r)
| |
X
|
X
|
X
|
X
|
|
14
|
Alcohol implicit assoc.
|
Valence IAT (r)
| |
X
|
X
|
X
|
X
|
|
15
|
Biomarkers chron. alc. use
|
GGT + CDT (b)
| |
X
|
X
|
X
|
X
|
- AUDIT Alcohol Use Disorders Identification Test, CDT carbohydrate-deficient transferrin, CRA-HS Community Reinforcement Approach Happiness Scale, DSM-IV Diagnostic and Statistical Manual – 4th ed., DTQ Desire Thinking Questionnaire, EQ-5D™ EuroQol - 5 dimensions, GGT serum γ-glutamyltransferase, IAT Implicit Association Task, M.I.N.I.-plus M.I.N.I. International Neuropsychiatric Interview-Plus, PACS Penn Alcohol Craving Scale, PANAS-SF Positive And Negative Affect Schedule – Short Form, PTQ Perseverative Thinking Questionnaire, RCQ-D Readiness to Change Questionnaire - Dutch version, SELD Self-Efficacy List for Drug users, TLFB Timeline Followback.
